One Platform. Complete Strategic Intelligence.
How Beacon Helps Senior Leadership Teams:
- Gain a complete view of evolving drug development landscapes to understand portfolio position, competitive pressure and external innovation.
- Monitor programmes against competitor milestones, clinical evidence and market developments to identify strategic risks and opportunities earlier.
- Prioritise portfolio, partnering and investment decisions using connected scientific, clinical, company and deal intelligence.
- Equip board and portfolio discussions with traceable, decision-grade evidence that aligns scientific, commercial and financial stakeholders.
Why Leading Senior Leadership Teams Choose Beacon
Beacon goes beyond generic databases and AI tools, delivering the connected, curated and defensible intelligence leaders need to set priorities, allocate resources and guide portfolio strategy.
Modality & Disease-Specific Datasets
Analyze the full competitive landscape. Includes the 20-30% of data AI engines miss.
Subject Matter Expert-Led Curation
Curated by scientists, trusted by strategists to deliver decision-grade intelligence
Holistic Preclinical & Clinical Data
From discovery to clinic, depth and context no generic platform can match.
Granular Ontologies & Modality-Specific Data
From “who is active” to “what wins” benchmark what drives differentiation.
Structured, AI-ready Data
Power your analytics and automation workflows. Gold-standard data in, gold-standard decisions out.
Why Generic Databases and AI Engines Fall Short
The difference is clear. Beacon delivers decision-grade intelligence designed specifically for drug development.
| What Matters | Generic Databases | AI Engines | Beacon |
| Landscape Completeness | Broad, but shallow | Highly variable; significant omissions | Access the full landscape, including the 20-30% others miss |
| Preclinical depth | Limited or absent | Largely missing from model outputs | Core strength, curated from grey literature upwards |
| Scientific granularity | Company, indication, phase of development | Unstructured narrative text | 90+ modality-specific filters and ontologies |
| Curation | Largely automated aggregation | None, model inference only | Curated by sector scientists, zero tolerance for errors |
| Consistency | Varies with refresh cycles and versioning | Answers vary between identical queries | Deterministic, the same query returns the same result |
| Defensibility | Partial sourcing; re-validation needed | Sources often missing, paraphrased or fabricated | 100% traceable, board and portfolio ready |
Lead with Decision-Grade Drug Development Intelligence
See the complete landscape, prioritise the right opportunities and make strategic decisions with confidence.
Search